揭秘「伟哥」背后，多数人不知道的商业故事

Core Viewpoint - The article discusses the confusion and risks associated with the purchase of erectile dysfunction (ED) medications, particularly focusing on the brand name "Viagra" and its misuse in the market, leading to consumer deception and health risks [2][9][50]. Group 1: Market Confusion - The term "伟哥" (Weige) has become a generic term for ED medications in China, leading to a proliferation of misleading products and advertisements [21][32]. - A significant portion of complaints related to "伟哥" includes false advertising (28%), product mismatches (20%), and counterfeit or unregulated products (19%) [9][45]. - The commercialization of "伟哥" has resulted in a disconnect between the original drug, Viagra, and the various products marketed under the same name, creating a chaotic marketplace [20][40]. Group 2: Historical Context - Viagra, originally approved by the FDA in 1998 as a cardiovascular drug, became the first oral PDE-5 inhibitor for ED treatment, significantly impacting both medical and cultural perceptions [15][18]. - The introduction of Viagra to the Chinese market in 2000 marked the beginning of a complex relationship between the drug's medical use and its cultural symbolism [19][20]. - The brand name "万艾可" (Wan Aike) was established for Viagra in China, while "伟哥" became a separate trademark owned by a domestic company, leading to brand confusion [25][36]. Group 3: Regulatory and Legal Issues - Legal disputes have arisen over whether "伟哥" should be considered a generic term, with the National Intellectual Property Administration ruling that it retains its trademark status [38]. - Pfizer has attempted to assert that "伟哥" is a well-known trademark, but courts have not consistently supported this claim [39][40]. - The fragmentation of trademark rights has contributed to ongoing brand confusion and legal challenges in the market [37]. Group 4: Consumer Risks - Consumers face significant risks when purchasing ED medications online, including exposure to counterfeit products and unregulated substances that may contain harmful ingredients [46][59]. - The lack of clear labeling and the prevalence of misleading marketing tactics complicate the consumer's ability to make informed choices [44][45]. - The article emphasizes the importance of purchasing medications through legitimate channels and verifying product authenticity to mitigate health risks [54][60].